Johns Hopkins scientists develop mRNA "booster" as potential new way to treat rare genetic diseases marked by too low levels of specific cellular proteins
America's biomedical research engine has produced lifesaving treatments for cancer and other diseases. Cuts to funding harm the lives and futures of Americans.
EpiScalp could significantly reduce false positives and spare patients from medication side effects, driving restrictions, and other quality-of-life challenges linked to misdiagnoses
Johns Hopkins scientists have pioneered a new color-changing hydrogel that could reduce complications from cataract surgery, one of the world's most commonly performed procedures
Using a cutting-edge technique, Hopkins researchers present a potential clinical tool to predict waist circumference and identify patients at risk for obesity complications